chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Fatigue, Headache, Nausea
Clinical narrative: Body aches; Abdominal pain (right); Fatigue; Chills; Nausea; Headache; Fever; Pain at injection site left; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain (right)), FATIGUE (Fatigue), VACCINATION SITE PAIN (Pain at injection site left) and CHILLS (Chills) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 025JZo2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site left). On 20-Jan-2021, the patient experienced PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain (right)), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 21-Jan-2021, CHILLS (Chills), NAUSEA (Nausea) and HEADACHE (Headache) had resolved. At the time of the report, PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain (right)), FATIGUE (Fatigue) and PYREXIA (Fever) outcome was unknown and VACCINATION SITE PAIN (Pain at injection site left) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Urine analysis: abnormal (abnormal) Blood in urine.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided Treatment information provided as "antibiotic prescribed o/s BID started 21JAN2021"; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Urine analysis, Vaccination site pain
Clinical narrative: Body aches; Abdominal pain (right); Fatigue; Chills; Nausea; Headache; Fever; Pain at injection site left; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain (right)), FATIGUE (Fatigue), VACCINATION SITE PAIN (Pain at injection site left) and CHILLS (Chills) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 025JZo2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site left). On 20-Jan-2021, the patient experienced PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain (right)), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 21-Jan-2021, CHILLS (Chills), NAUSEA (Nausea) and HEADACHE (Headache) had resolved. At the time of the report, PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain (right)), FATIGUE (Fatigue) and PYREXIA (Fever) outcome was unknown and VACCINATION SITE PAIN (Pain at injection site left) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Urine analysis: abnormal (abnormal) Blood in urine.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided Treatment information provided as "antibiotic prescribed o/s BID started 21JAN2021"; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Feeling tired) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025302A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced FATIGUE (Feeling tired). At the time of the report, FATIGUE (Feeling tired) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: TCR; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Insomnia, Pain, Pain in extremity
Clinical narrative: couldn't sleep; severe arm pain; upper arm burning pain; collar bone pain; shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (couldn't sleep), PAIN IN EXTREMITY (severe arm pain), ARTHRALGIA (shoulder pain), PAIN (upper arm burning pain) and BONE PAIN (collar bone pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (couldn't sleep), PAIN IN EXTREMITY (severe arm pain), ARTHRALGIA (shoulder pain), PAIN (upper arm burning pain) and BONE PAIN (collar bone pain). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, INSOMNIA (couldn't sleep), PAIN IN EXTREMITY (severe arm pain) and PAIN (upper arm burning pain) outcome was unknown, ARTHRALGIA (shoulder pain) was resolving and BONE PAIN (collar bone pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Injection site was red; Injection site itchy; Injection site swollen; Pain on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on the left arm), VACCINATION SITE ERYTHEMA (Injection site was red), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE SWELLING (Injection site swollen) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: TETANUS VACCINE.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain on the left arm). On 14-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site was red), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE SWELLING (Injection site swollen). On 08-Jan-2021, PAIN IN EXTREMITY (Pain on the left arm) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Injection site was red), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE SWELLING (Injection site swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site mass, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: arm was swollen under the injection site like a ball; arm was hot to the touch; arm was really itchy; swelling of the arm/arm was swollen; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (arm was swollen under the injection site like a ball), VACCINATION SITE WARMTH (arm was hot to the touch), VACCINATION SITE PRURITUS (arm was really itchy) and VACCINATION SITE SWELLING (swelling of the arm/arm was swollen) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. MLs-319813_r) for COVID-19 vaccination.     No Medical History information was reported.  On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 04-Jan-2021, the patient experienced VACCINATION SITE SWELLING (swelling of the arm/arm was swollen).   On 12-Jan-2021, the patient experienced INJECTION SITE MASS (arm was swollen under the injection site like a ball), VACCINATION SITE WARMTH (arm was hot to the touch) and VACCINATION SITE PRURITUS (arm was really itchy).   On 07-Jan-2021, VACCINATION SITE SWELLING (swelling of the arm/arm was swollen) had resolved. At the time of the report, INJECTION SITE MASS (arm was swollen under the injection site like a ball), VACCINATION SITE WARMTH (arm was hot to the touch) and VACCINATION SITE PRURITUS (arm was really itchy) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Headache, Nausea
Clinical narrative: metallic taste on the back of the throat; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste on the back of the throat), NAUSEA (nausea) and HEADACHE (headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) and VITAMINS NOS (MULTI-VIT) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DYSGEUSIA (metallic taste on the back of the throat), NAUSEA (nausea) and HEADACHE (headache). At the time of the report, DYSGEUSIA (metallic taste on the back of the throat), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications also include water pill, No Treatment information provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021 at 10:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 13-Jan-2021, the patient experienced PYREXIA (Fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever) and CHILLS (chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PYREXIA (Fever ) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included Paraneoplastic syndrome and Cancer. Concurrent medical conditions included Blood pressure and Cholesterol. Concomitant products included SIMVASTATIN for Cholesterol, LISINOPRIL for Hypertension, Durvalumab.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PYREXIA (Fever ). On 16-Jan-2021, PYREXIA (Fever ) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, Body temperature: 101.7. On 15-Jan-2021, Body temperature: 101.1. On 16-Jan-2021, Body temperature: 99.9.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Hypersensitivity, Throat tightness, Urticaria
Clinical narrative: chest pressure; throat closing; whole face with hives; allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced HYPERSENSITIVITY (allergic reaction). On 15-Jan-2021, HYPERSENSITIVITY (allergic reaction) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. treatment medication includes antihistamines   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: NNI
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea, Oropharyngeal pain, Temperature regulation disorder
Clinical narrative: severe dizziness; Nausea; vomiting (dry heaving); extreme fatigue/feeling of being washed out; sore throat; low grade temperature; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), TEMPERATURE REGULATION DISORDER (low grade temperature), DIZZINESS (severe dizziness), NAUSEA (Nausea) and VOMITING (vomiting (dry heaving)) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20/2019(?)) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product IBUPROFEN for an unknown indication.    Concurrent medical conditions included Sore throat on 11-Jan-2021 and Temperature body decrease on 11-Jan-2021.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient started IBUPROFEN (unknown route) at an unspecified dose. On 11-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat) and TEMPERATURE REGULATION DISORDER (low grade temperature). On 17-Jan-2021, the patient experienced DIZZINESS (severe dizziness), NAUSEA (Nausea), VOMITING (vomiting (dry heaving)) and FATIGUE (extreme fatigue/feeling of being washed out). The patient was treated with PARACETAMOL (TYLENOL) on 18-Jan-2021 at an unspecified dose and frequency; IBUPROFEN (MOTRIN CHILDREN) on 18-Jan-2021 at an unspecified dose and frequency and Lozenges at an unspecified dose and frequency. On 11-Jan-2021, OROPHARYNGEAL PAIN (sore throat) and TEMPERATURE REGULATION DISORDER (low grade temperature) had resolved. On 18-Jan-2021, NAUSEA (Nausea) and VOMITING (vomiting (dry heaving)) had resolved. At the time of the report, DIZZINESS (severe dizziness) and FATIGUE (extreme fatigue/feeling of being washed out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded, however the events may have an alternative cause. Further information have been requested.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: severe dizziness; Nausea; vomiting (dry heaving); extreme fatigue/feeling of being washed out; sore throat; low grade temperature; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), TEMPERATURE REGULATION DISORDER (low grade temperature), DIZZINESS (severe dizziness), NAUSEA (Nausea) and VOMITING (vomiting (dry heaving)) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20/2019(?)) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product IBUPROFEN for an unknown indication.    Concurrent medical conditions included Sore throat on 11-Jan-2021 and Temperature body decrease on 11-Jan-2021.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient started IBUPROFEN (unknown route) at an unspecified dose. On 11-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat) and TEMPERATURE REGULATION DISORDER (low grade temperature). On 17-Jan-2021, the patient experienced DIZZINESS (severe dizziness), NAUSEA (Nausea), VOMITING (vomiting (dry heaving)) and FATIGUE (extreme fatigue/feeling of being washed out). The patient was treated with PARACETAMOL (TYLENOL) on 18-Jan-2021 at an unspecified dose and frequency; IBUPROFEN (MOTRIN CHILDREN) on 18-Jan-2021 at an unspecified dose and frequency and Lozenges at an unspecified dose and frequency. On 11-Jan-2021, OROPHARYNGEAL PAIN (sore throat) and TEMPERATURE REGULATION DISORDER (low grade temperature) had resolved. On 18-Jan-2021, NAUSEA (Nausea) and VOMITING (vomiting (dry heaving)) had resolved. At the time of the report, DIZZINESS (severe dizziness) and FATIGUE (extreme fatigue/feeling of being washed out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded, however the events may have an alternative cause. Further information have been requested.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash, Vaccination site swelling
Clinical narrative: redness at the injection site; swelling at the injection site; rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE RASH (rash at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE RASH (rash at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE RASH (rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (injection site pain). At the time of the report, VACCINATION SITE PAIN (injection site pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site infection, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Infection at injection site; Injection site had a red mark; Injection site was swollen; Injection site was tender; Injection site was itching; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE ERYTHEMA (Injection site had a red mark), INJECTION SITE SWELLING (Injection site was swollen), INJECTION SITE PAIN (Injection site was tender), INJECTION SITE PRURITUS (Injection site was itching) and INJECTION SITE INFECTION (Infection at injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (Reported as allergic to PCN).    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Injection site had a red mark), INJECTION SITE SWELLING (Injection site was swollen), INJECTION SITE PAIN (Injection site was tender) and INJECTION SITE PRURITUS (Injection site was itching). On 12-Jan-2021, the patient experienced INJECTION SITE INFECTION (Infection at injection site). On 17-Jan-2021, INJECTION SITE SWELLING (Injection site was swollen) and INJECTION SITE PAIN (Injection site was tender) outcome was unknown. At the time of the report, INJECTION SITE ERYTHEMA (Injection site had a red mark), INJECTION SITE PRURITUS (Injection site was itching) and INJECTION SITE INFECTION (Infection at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Cough, Dysphagia, Ear pain
Clinical narrative: Headaches; off and on ear pain; fever goes up and down; stuffed up; started coughing; Hard to swallow; sleeping a lot; 100.3 degree fever last night; chills that are ongoing; chest feels heavy (like asthma feeling); bumpy at the injection site; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), INJECTION SITE NODULE (bumpy at the injection site), HEADACHE (Headaches), CHEST DISCOMFORT (chest feels heavy (like asthma feeling)) and COUGH (started coughing) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     medical history not reported.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 16-Jan-2021, the patient experienced INJECTION SITE NODULE (bumpy at the injection site) and CHEST DISCOMFORT (chest feels heavy (like asthma feeling)). On 17-Jan-2021, the patient experienced COUGH (started coughing), DYSPHAGIA (Hard to swallow), SOMNOLENCE (sleeping a lot), PYREXIA (100.3 degree fever last night) and CHILLS (chills that are ongoing). On 18-Jan-2021, the patient experienced HEADACHE (Headaches), EAR PAIN (off and on ear pain), PYREXIA (fever goes up and down) and NASAL CONGESTION (stuffed up). At the time of the report, PAIN IN EXTREMITY (sore arm), INJECTION SITE NODULE (bumpy at the injection site), HEADACHE (Headaches), CHEST DISCOMFORT (chest feels heavy (like asthma feeling)), DYSPHAGIA (Hard to swallow), SOMNOLENCE (sleeping a lot), PYREXIA (100.3 degree fever last night), CHILLS (chills that are ongoing), EAR PAIN (off and on ear pain), PYREXIA (fever goes up and down) and NASAL CONGESTION (stuffed up) had resolved and COUGH (started coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included unspecified over the counter vitamins.  Treatment for the events included paracetamol.    Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: No new information
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site nodule, Nasal congestion, Pain in extremity, Pyrexia
Clinical narrative: Headaches; off and on ear pain; fever goes up and down; stuffed up; started coughing; Hard to swallow; sleeping a lot; 100.3 degree fever last night; chills that are ongoing; chest feels heavy (like asthma feeling); bumpy at the injection site; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), INJECTION SITE NODULE (bumpy at the injection site), HEADACHE (Headaches), CHEST DISCOMFORT (chest feels heavy (like asthma feeling)) and COUGH (started coughing) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     medical history not reported.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 16-Jan-2021, the patient experienced INJECTION SITE NODULE (bumpy at the injection site) and CHEST DISCOMFORT (chest feels heavy (like asthma feeling)). On 17-Jan-2021, the patient experienced COUGH (started coughing), DYSPHAGIA (Hard to swallow), SOMNOLENCE (sleeping a lot), PYREXIA (100.3 degree fever last night) and CHILLS (chills that are ongoing). On 18-Jan-2021, the patient experienced HEADACHE (Headaches), EAR PAIN (off and on ear pain), PYREXIA (fever goes up and down) and NASAL CONGESTION (stuffed up). At the time of the report, PAIN IN EXTREMITY (sore arm), INJECTION SITE NODULE (bumpy at the injection site), HEADACHE (Headaches), CHEST DISCOMFORT (chest feels heavy (like asthma feeling)), DYSPHAGIA (Hard to swallow), SOMNOLENCE (sleeping a lot), PYREXIA (100.3 degree fever last night), CHILLS (chills that are ongoing), EAR PAIN (off and on ear pain), PYREXIA (fever goes up and down) and NASAL CONGESTION (stuffed up) had resolved and COUGH (started coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included unspecified over the counter vitamins.  Treatment for the events included paracetamol.    Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: No new information
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Headaches; off and on ear pain; fever goes up and down; stuffed up; started coughing; Hard to swallow; sleeping a lot; 100.3 degree fever last night; chills that are ongoing; chest feels heavy (like asthma feeling); bumpy at the injection site; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), INJECTION SITE NODULE (bumpy at the injection site), HEADACHE (Headaches), CHEST DISCOMFORT (chest feels heavy (like asthma feeling)) and COUGH (started coughing) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     medical history not reported.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 16-Jan-2021, the patient experienced INJECTION SITE NODULE (bumpy at the injection site) and CHEST DISCOMFORT (chest feels heavy (like asthma feeling)). On 17-Jan-2021, the patient experienced COUGH (started coughing), DYSPHAGIA (Hard to swallow), SOMNOLENCE (sleeping a lot), PYREXIA (100.3 degree fever last night) and CHILLS (chills that are ongoing). On 18-Jan-2021, the patient experienced HEADACHE (Headaches), EAR PAIN (off and on ear pain), PYREXIA (fever goes up and down) and NASAL CONGESTION (stuffed up). At the time of the report, PAIN IN EXTREMITY (sore arm), INJECTION SITE NODULE (bumpy at the injection site), HEADACHE (Headaches), CHEST DISCOMFORT (chest feels heavy (like asthma feeling)), DYSPHAGIA (Hard to swallow), SOMNOLENCE (sleeping a lot), PYREXIA (100.3 degree fever last night), CHILLS (chills that are ongoing), EAR PAIN (off and on ear pain), PYREXIA (fever goes up and down) and NASAL CONGESTION (stuffed up) had resolved and COUGH (started coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included unspecified over the counter vitamins.  Treatment for the events included paracetamol.    Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: No new information
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Vaccination site pain
Clinical narrative: Soreness at injection site; Small cough at night; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site) and COUGH (Small cough at night) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 41L20A) for COVID-19 vaccination.     The patient's past medical history included Coronary artery disease, Pneumonia, Immune system disorder and Peripheral artery surgery.   On 18-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose.   On 18-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site) and COUGH (Small cough at night). At the time of the report, VACCINATION SITE PAIN (Soreness at injection site) and COUGH (Small cough at night) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It is reported that patient had other health conditions as 22 stamps and currently taking infusions for low immune system. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2021: No specific follow-up information recorded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chest pain, Dizziness, Fatigue
Clinical narrative: Chest pain; Lung pain; Back pain; back pain on her left side; joint pain; Warm wave went across my chest after the shot; Full blown flu-like symptoms; Slept all day; Joint Pain; fatigue; fever; Nausea; Dizziness; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warm wave went across my chest after the shot), INFLUENZA LIKE ILLNESS (Full blown flu-like symptoms), SOMNOLENCE (Slept all day), CHEST PAIN (Chest pain) and PULMONARY PAIN (Lung pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced FEELING HOT (Warm wave went across my chest after the shot), INFLUENZA LIKE ILLNESS (Full blown flu-like symptoms), SOMNOLENCE (Slept all day), ARTHRALGIA (Joint Pain), FATIGUE (fatigue), PYREXIA (fever), NAUSEA (Nausea), DIZZINESS (Dizziness), the first episode of ARTHRALGIA (joint pain) and the second episode of ARTHRALGIA (joint pain). On 17-Jan-2021, the patient experienced CHEST PAIN (Chest pain), PULMONARY PAIN (Lung pain), BACK PAIN (Back pain) and BACK PAIN (back pain on her left side). On 17-Jan-2021, FEELING HOT (Warm wave went across my chest after the shot), INFLUENZA LIKE ILLNESS (Full blown flu-like symptoms), SOMNOLENCE (Slept all day), ARTHRALGIA (Joint Pain), FATIGUE (fatigue), PYREXIA (fever), NAUSEA (Nausea), DIZZINESS (Dizziness) and the last episode of ARTHRALGIA (joint pain) outcome was unknown. At the time of the report, CHEST PAIN (Chest pain), PULMONARY PAIN (Lung pain), BACK PAIN (Back pain) and BACK PAIN (back pain on her left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Influenza like illness, Nausea, Pulmonary pain, Pyrexia
Clinical narrative: Chest pain; Lung pain; Back pain; back pain on her left side; joint pain; Warm wave went across my chest after the shot; Full blown flu-like symptoms; Slept all day; Joint Pain; fatigue; fever; Nausea; Dizziness; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warm wave went across my chest after the shot), INFLUENZA LIKE ILLNESS (Full blown flu-like symptoms), SOMNOLENCE (Slept all day), CHEST PAIN (Chest pain) and PULMONARY PAIN (Lung pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced FEELING HOT (Warm wave went across my chest after the shot), INFLUENZA LIKE ILLNESS (Full blown flu-like symptoms), SOMNOLENCE (Slept all day), ARTHRALGIA (Joint Pain), FATIGUE (fatigue), PYREXIA (fever), NAUSEA (Nausea), DIZZINESS (Dizziness), the first episode of ARTHRALGIA (joint pain) and the second episode of ARTHRALGIA (joint pain). On 17-Jan-2021, the patient experienced CHEST PAIN (Chest pain), PULMONARY PAIN (Lung pain), BACK PAIN (Back pain) and BACK PAIN (back pain on her left side). On 17-Jan-2021, FEELING HOT (Warm wave went across my chest after the shot), INFLUENZA LIKE ILLNESS (Full blown flu-like symptoms), SOMNOLENCE (Slept all day), ARTHRALGIA (Joint Pain), FATIGUE (fatigue), PYREXIA (fever), NAUSEA (Nausea), DIZZINESS (Dizziness) and the last episode of ARTHRALGIA (joint pain) outcome was unknown. At the time of the report, CHEST PAIN (Chest pain), PULMONARY PAIN (Lung pain), BACK PAIN (Back pain) and BACK PAIN (back pain on her left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Chest pain; Lung pain; Back pain; back pain on her left side; joint pain; Warm wave went across my chest after the shot; Full blown flu-like symptoms; Slept all day; Joint Pain; fatigue; fever; Nausea; Dizziness; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warm wave went across my chest after the shot), INFLUENZA LIKE ILLNESS (Full blown flu-like symptoms), SOMNOLENCE (Slept all day), CHEST PAIN (Chest pain) and PULMONARY PAIN (Lung pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced FEELING HOT (Warm wave went across my chest after the shot), INFLUENZA LIKE ILLNESS (Full blown flu-like symptoms), SOMNOLENCE (Slept all day), ARTHRALGIA (Joint Pain), FATIGUE (fatigue), PYREXIA (fever), NAUSEA (Nausea), DIZZINESS (Dizziness), the first episode of ARTHRALGIA (joint pain) and the second episode of ARTHRALGIA (joint pain). On 17-Jan-2021, the patient experienced CHEST PAIN (Chest pain), PULMONARY PAIN (Lung pain), BACK PAIN (Back pain) and BACK PAIN (back pain on her left side). On 17-Jan-2021, FEELING HOT (Warm wave went across my chest after the shot), INFLUENZA LIKE ILLNESS (Full blown flu-like symptoms), SOMNOLENCE (Slept all day), ARTHRALGIA (Joint Pain), FATIGUE (fatigue), PYREXIA (fever), NAUSEA (Nausea), DIZZINESS (Dizziness) and the last episode of ARTHRALGIA (joint pain) outcome was unknown. At the time of the report, CHEST PAIN (Chest pain), PULMONARY PAIN (Lung pain), BACK PAIN (Back pain) and BACK PAIN (back pain on her left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Pruritus, Tenderness
Clinical narrative: Redness at site of vaccine; vaccine site visibly swollen; Injection site is warm to touch; ITCHY; TENDER; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness), INJECTION SITE ERYTHEMA (Redness at site of vaccine), VACCINATION SITE SWELLING (vaccine site visibly swollen), INJECTION SITE WARMTH (Injection site is warm to touch) and PRURITUS (ITCHY) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced INJECTION SITE PAIN (Soreness). On 20-Jan-2021, the patient experienced PRURITUS (ITCHY) and TENDERNESS (TENDER). On 21-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Redness at site of vaccine), VACCINATION SITE SWELLING (vaccine site visibly swollen) and INJECTION SITE WARMTH (Injection site is warm to touch). At the time of the report, INJECTION SITE PAIN (Soreness), INJECTION SITE ERYTHEMA (Redness at site of vaccine), VACCINATION SITE SWELLING (vaccine site visibly swollen), INJECTION SITE WARMTH (Injection site is warm to touch), PRURITUS (ITCHY) and TENDERNESS (TENDER) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications are not reported.  No treatment information was provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Redness at site of vaccine; vaccine site visibly swollen; Injection site is warm to touch; ITCHY; TENDER; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness), INJECTION SITE ERYTHEMA (Redness at site of vaccine), VACCINATION SITE SWELLING (vaccine site visibly swollen), INJECTION SITE WARMTH (Injection site is warm to touch) and PRURITUS (ITCHY) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced INJECTION SITE PAIN (Soreness). On 20-Jan-2021, the patient experienced PRURITUS (ITCHY) and TENDERNESS (TENDER). On 21-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Redness at site of vaccine), VACCINATION SITE SWELLING (vaccine site visibly swollen) and INJECTION SITE WARMTH (Injection site is warm to touch). At the time of the report, INJECTION SITE PAIN (Soreness), INJECTION SITE ERYTHEMA (Redness at site of vaccine), VACCINATION SITE SWELLING (vaccine site visibly swollen), INJECTION SITE WARMTH (Injection site is warm to touch), PRURITUS (ITCHY) and TENDERNESS (TENDER) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications are not reported.  No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Breast pain, Pain in extremity, X-ray
Clinical narrative: pain in the back of shoulders; pain in the left arm (no site of injection); pain in the left breast; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in the back of shoulders), PAIN IN EXTREMITY (pain in the left arm (no site of injection)) and BREAST PAIN (pain in the left breast) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 28-Dec-2020, the patient experienced ARTHRALGIA (pain in the back of shoulders), PAIN IN EXTREMITY (pain in the left arm (no site of injection)) and BREAST PAIN (pain in the left breast).   The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date for Pain, at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (pain in the back of shoulders), PAIN IN EXTREMITY (pain in the left arm (no site of injection)) and BREAST PAIN (pain in the left breast) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: unknown Unknown.  For mRNA-1273 (COVID 19 Vaccine Moderna) administered intramuscularly, the reporter did not provide any causality assessments.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant medication was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A20A) for COVID-19 vaccination.     The patient's past medical history included Injury (Foot ball injury).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (back pain). At the time of the report, BACK PAIN (back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided. Consumer reports that back pain is due to prior football injury.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea for 5 days; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea for 5 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 15-Jan-2021, the patient experienced DIARRHOEA (diarrhea for 5 days). On 20-Jan-2021, DIARRHOEA (diarrhea for 5 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.